Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology- United States

doi 10.1124/mol.118.114348

Full Text

Abstract

Available in

Categories

Molecular Medicine

Date

January 29, 2019

Authors

Elena Popugaeva

Tatyana Y. Postnikova

Vladimir Poroikov

Aleksey V. Zaitsev

Ilya Bezprozvanny

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Glycodendrimers and Their Derivatives as Potential Therapeutic Agents

Macroheterocycles

Organic Chemistry

Analytical Chemistry

English

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

The Characterization of Microtubule-Stabilizing Drugs as Possible Therapeutic Agents for Alzheimer's Disease and Related Tauopathies

Pharmacological Research

English

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

English

Microglial Inflammation and Phagocytosis in Alzheimer's Disease: Potential Therapeutic Targets

British Journal of Pharmacology

English

Imidazole Derivatives as Promising Agents for the Treatment of Chagas Disease†

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Therapeutic Perspectives in Alzheimer's Disease

Recent Patents on CNS Drug Discovery

English

Selecting for Neurogenic Potential as an Alternative for Alzheimer's Disease Drug Discovery

Alzheimer's and Dementia

Molecular Neuroscience

Developmental Neuroscience

English

Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English